Gauss

F12 (human) recombinant (full lengh t protein gst tag) 10 µg

Réf. UGAP : 3812442 Réf. Fournisseur : 16164761 Réf. Constructeur : H00002161-P02
Franco de port et d'emballage pour toutes les commandes supérieures à 80€ HT.

Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
La quantité choisie doit être comprise entre 1 et 999 999.
Il ne reste que 0 exemplaires.

Points clés

Used for AP, Array, ELISA, WB-Re

This gene encodes coagulation factor XII which circulates in blood as a zymogen. This single chain zymogen is converted to a two-chain serine protease with an heavy chain (alpha-factor XIIa) and a light chain. The heavy chain contains two fibronectin-type domains, two epidermal growth factor (EGF)-like domains, a kringle domain and a proline-rich domain, whereas the light chain contains only a catalytic domain. On activation, further cleavages takes place in the heavy chain, resulting in the production of beta-factor XIIa light chain and the alpha-factor XIIa light chain becomes beta-factor XIIa heavy chain. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then to beta-factor XIIa. The active factor XIIa participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. It activates coagulation factors VII and XI. Defects in this gene do not cause any clinical symptoms and the sole effect is that whole-blood clotting time is prolonged. [provided by RefSeq]

En savoir plus

Garantie

Garantie 0 Mois

Description

Used for AP, Array, ELISA, WB-Re

This gene encodes coagulation factor XII which circulates in blood as a zymogen. This single chain zymogen is converted to a two-chain serine protease with an heavy chain (alpha-factor XIIa) and a light chain. The heavy chain contains two fibronectin-type domains, two epidermal growth factor (EGF)-like domains, a kringle domain and a proline-rich domain, whereas the light chain contains only a catalytic domain. On activation, further cleavages takes place in the heavy chain, resulting in the production of beta-factor XIIa light chain and the alpha-factor XIIa light chain becomes beta-factor XIIa heavy chain. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then to beta-factor XIIa. The active factor XIIa participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. It activates coagulation factors VII and XI. Defects in this gene do not cause any clinical symptoms and the sole effect is that whole-blood clotting time is prolonged. [provided by RefSeq]

Caractéristiques

Fournisseur
FISHER SCIENTIFIC S.A.S.
Marque
ABNOVA
Référence fabricant
H00002161-P02
Référence distributeur
16164761
Vendu par
10 ug
Quantité
N/A
Lieu de fabrication
Taiwan
Lieu de stockage
France
Délai de péremption à la date de livraison
12 mois
Code à barre
non
Soumis à carboglace
oui
Libellé produit fabricant
10ug f12 (human) recombinant protein (p02)
Certification
RUO
Marquage CE DIV
non
Type de produit
protéine
Type de protéine
oui
Type d'antibiotique
non
Type d'enzyme
non
Température de conservation (°C)
-80 °C
Température de transport
carboglace
Dispositif stérile
non
Type d'acide nucléique extrait
non
Origine humaine
non
Sans composant animal
non
Matière dangereuse
non
Autres caractéristiques
Abnova Human F12 Full-length ORF (AAH12390.1, 1 a.a. - 300 a.a.) Recombinant Protein with GST-tag at N-terminal, Quantity: 10 ug, Format: Liquid, Formulation: 50mM Tris-HCI, 10mM reduced Glutathione, pH-8.0 in the elution buffer., Host Species: Wheat
Classification REACH
non
Code douanier
38229000
Nomenclature Nacres
NA.55
Nomenclature CEA
SGP01
Nomenclature IRSN
273
Nomenclature INSERM
NA.NA55
Nomenclature CNRS
NA55
Nomenclature CHU
18.551
Nomenclature DGOS
LD10AOOO
Domaine de recherche
protéomique
Type d’application
ELISA, Western-Blot
Type d'échantillon
protéine
Reprise en cas d’erreur client
non